/Dr. Yuval Yarkoni
Expert outlook on ADC manufacturing
Expert outlook on ADC manufacturing
23 Sept 2024

With over 20 years of experience in molecular immunology, Dr. Yuval Yarkoni expertly navigates the complexities of antibody-drug conjugate (ADC) manufacturing, from process development and supply chain to quality assurance and regulatory challenges. Dr. Yarkoni provides a compelling glimpse into the future of oncology, highlighting the scientific advancements and meticulous processes that drive the creation of these innovative therapies.